Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000902392) titled 'Use of an electronic nose (SpiroNose(R)) to diagnose respiratory symptoms, lung abnormalities and sleep disorders' on July 22.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Primary Sponsor: Woolcock Institute of Medical Research
Condition:
Asthma
Chronic obstructive pulmonary disease
Bronchiectasis
Interstitial lung diseases (ILDs)
Interstitial lung abnormalities (ILAs)
Environmental lung disease
Pleural diseases
Lung cancer
Pulmonary nodules
Cardiac failure
Vaping-associated pulmonary injury (EVALI)
Narcolepsy
Obstructive sleep apnoea (OSA)
Asthma
Chronic ob...